Lumida
/TARS
⌘K
Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals Inc

TARS
$79.31USD-2.23%-1.81 today

MARKET CAP

3.5B

P/E (TTM)

FWD P/E

DAY RANGE

$79 – $83

52W RANGE

$48
$92

AI Summary

Stalk
StalkMedium

TARS has erupted to new highs after breaking out of a prolonged consolidation on strong institutional volume, with moving averages aligned and heavy options bullishness; however, extreme overbought readings and steep extension above key EMAs warrant deferring fresh entries until a shallow pullback into the broken-resistance zone near $79–$80 or into the rising 9/20 EMAs for optimal execution alignment.

  • Xtemvi Q2 product sales hit $173.9M, up 69% YoY.
  • Full-year Xtemvi guidance boosted to $685M on expected Q4 patient growth.
  • Adjusted loss widened to $0.43 per share, highlighting profitability risk.
Full analysis →

Buying

10

institutions

Selling

5

institutions

New Positions

2

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
JH

Janus Henderson Group Plc

Q1 2026

BUY4.48 M314.45 M+2.55 M+98.9%0.08%
BI

Blackrock, Inc.

Q2 2026

BUY3.86 M242.71 M+303.52 K-2.6%0.00%
RI

Rtw Investments, LP

Q2 2026

BUY3.36 M211.29 M+11.03 K-10.0%1.80%
MM

Millennium Management LLC

Q2 2026

BUY1.46 M91.71 M+862.54 K+119.9%0.03%
CA

Citadel Advisors LLC

Q2 2026

BUY274.14 K17.25 M+91.04 K+34.3%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY139.98 K8.68 M+109.50 K+325.8%0.00%
WP

Woodline Partners LP

Q2 2026

SELL100.44 K6.32 M+-100.44 K-55.1%0.02%
EP

Eversept Partners, LP

Q2 2026

BUYNEW55.71 K3.51 M+55.71 K+0.0%0.18%
AC

Aqr Capital Management LLC

Q2 2026

BUY42.00 K2.64 M+11.55 K+23.8%0.00%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

BUY21.00 K1.32 M+4.20 K+12.2%0.30%
RT

Renaissance Technologies LLC

Q2 2026

SELL9.30 K585.34 K+-64.10 K-88.6%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW7.99 K503.08 K+7.99 K+0.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL1.41 K88.62 K+-22.00-11.7%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-226.25 K-100.0%0.00%
MG

Man Group Plc

Q2 2026

SELL0.000.00+-23.25 K-100.0%0.00%